Edesa Biotech (EDSA) Other Operating Expenses (2013 - 2020)

Edesa Biotech (EDSA) posted Other Operating Expenses of $2314.0 for Q3 2020, up 630.73% sequentially from -$436.0 in Q2 2020.

Edesa Biotech (EDSA) Other Operating Expenses (2013 - 2020) Analysis & Trends

Edesa Biotech has reported Other Operating Expenses for 8 years, with the latest figure at $2314.0 in Q3 2020.

Quarterly Other Operating Expenses changed N/A year-over-year to $2314.0 in Q3 2020, while the trailing twelve-month figure through Jun 2021 was $2314.0 (down 82.7% YoY) and the FY2020 annual result came in at $17601.0, down 82.62% from the prior year.
Other Operating Expenses grew to $2314.0 in Q3 2020 per EDSA's latest filing, from -$436.0 in the prior quarter.
Over five years, Other Operating Expenses peaked at $348150.0 in Q1 2016 and troughed at -$436.0 in Q2 2020.
A 5-year average of $107558.8 and a median of $100851.0 in 2017 frame the typical range for Other Operating Expenses.
The sharpest annual moves came in 2016 and 2020: Other Operating Expenses soared 200.76% in 2016, then tumbled 120.07% in 2020.
Over 5 years, Other Operating Expenses stood at $163400.0 in 2016, then sank by 38.28% to $100851.0 in 2017, then fell by 11.44% to $89314.0 in 2018, then sank by 95.77% to $3778.0 in 2019, then plunged by 38.75% to $2314.0 in 2020.
According to Business Quant data, Other Operating Expenses over the past three periods registered $2314.0, -$436.0, and $10037.0 for Q3 2020, Q2 2020, and Q1 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Edesa Biotech	40.44 Mn	40.44 Mn	-

Download Data